Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Palbociclib | 0.031623 | uM | 1 | 5000.00 | 1498.27 | 3503.00 | 4705.25 | 0.7424 | 0.6635 |
| MCF7 | Palbociclib | 0.1 | uM | 1 | 5000.00 | 1498.27 | 3751.67 | 4705.25 | 0.7956 | 0.7351 |
| MCF7 | Palbociclib | 0.31623 | uM | 1 | 5000.00 | 1498.27 | 2825.33 | 4705.25 | 0.6004 | 0.4660 |
| MCF7 | Palbociclib | 1 | uM | 1 | 5000.00 | 1498.27 | 2643.67 | 4705.25 | 0.5620 | 0.4100 |
| MCF7 | Palbociclib | 3.1623 | uM | 1 | 5000.00 | 1498.27 | 2689.67 | 4705.25 | 0.5719 | 0.4249 |
| MCF7 | Palbociclib | 10 | uM | 1 | 5000.00 | 1498.27 | 2379.00 | 4705.25 | 0.5040 | 0.3173 |
| MCF7 | Palbociclib | 19.9526 | uM | 1 | 5000.00 | 1498.27 | 2308.67 | 4705.25 | 0.4902 | 0.2967 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 156.25 | 28.40 | 143.00 | 120.42 | 1.1825 | 1.1568 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 156.25 | 28.40 | 141.67 | 120.42 | 1.1756 | 1.1607 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 156.25 | 28.40 | 109.33 | 120.42 | 0.9126 | 0.8932 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 156.25 | 28.40 | 117.67 | 120.42 | 0.9765 | 0.9766 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 156.25 | 28.40 | 139.00 | 120.42 | 1.1571 | 1.1458 |
| BT-20 | Erlotinib | 1 | uM | 7 | 156.25 | 28.40 | 142.00 | 120.42 | 1.1744 | 1.1510 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 156.25 | 28.40 | 126.67 | 120.42 | 1.0562 | 1.0497 |
| BT-20 | Erlotinib | 10 | uM | 7 | 156.25 | 28.40 | 121.00 | 120.42 | 1.0104 | 1.0072 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 156.25 | 28.40 | 176.00 | 120.42 | 1.4450 | 1.3475 |
| BT-20 | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 133.67 | 282.33 | 281.33 | 1.0031 | 1.0041 |
| BT-20 | Erlotinib | 0.01 | uM | 7 | 312.50 | 133.67 | 298.33 | 281.33 | 1.0599 | 1.1095 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 312.50 | 133.67 | 300.67 | 281.33 | 1.0693 | 1.1289 |
| BT-20 | Erlotinib | 0.1 | uM | 7 | 312.50 | 133.67 | 353.00 | 281.33 | 1.2551 | 1.4721 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 312.50 | 133.67 | 321.00 | 281.33 | 1.1412 | 1.2626 |
| BT-20 | Erlotinib | 1 | uM | 7 | 312.50 | 133.67 | 312.00 | 281.33 | 1.1094 | 1.2039 |
| BT-20 | Erlotinib | 3.1623 | uM | 7 | 312.50 | 133.67 | 318.33 | 281.33 | 1.1308 | 1.2403 |
| BT-20 | Erlotinib | 10 | uM | 7 | 312.50 | 133.67 | 265.00 | 281.33 | 0.9409 | 0.8865 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 312.50 | 133.67 | 319.00 | 281.33 | 1.1396 | 1.2600 |